Editorial introductions

Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Matteo BassettiMatteo BassettiMatteo Bassetti is Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. He is also Chief of Infectious Diseases Regional Department of Regione Liguria. Dr Bassetti is Chair of the Critically Ill Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). HE is spokesman of Italian Scientists Association (ISA). He serves on the editorial board of several prestigious international journals. He is author or co-author of more than 1000 papers (H index 125; 60000 citations) published in international peer-review journals and several chapters in books on COVID-19, antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients. Wei Shen LimWei Shen LimProfessor Wei Shen Lim is consultant respiratory physician at Nottingham University Hospitals NHS Trust and Honorary Professor of Respiratory Medicine, University of Nottingham, UK. He is chair of the Joint Committee of Vaccination and Immunisation (JCVI), UK and chair of the Acute Respiratory Infection National Strategy Research Group, National institute for Health and Care Research (NIHR) Respiratory Translational Research Centre. He co-led the evaluation of Dexamethasone for COVID-19 in the RECOVERY TRIAL and has been involved with the British Thoracic Society (BTS) and the National Institute for Health and Care Excellence (NICE) in the development of various national clinical management guidelines for acute respiratory infections including community-acquired pneumonia, pandemic influenza and COVID-19. He developed the CURB-65 severity assessment score for community-acquired pneumonia and the BTS community-acquired pneumonia care bundle. For his contributions towards respiratory infections, he was awarded the British Thoracic Society Meritorious Award in 2016, the Moxon Medal by the Royal College of Physicians (London) in 2021 and the British Thoracic Society President's award in 2023. He was appointed honorary Knight Commander of the most Excellent Order of the British Empire (KBE) in 2024, for services to COVID-19 vaccination.